Insider Transactions in Q1 2021 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Kenneth C Frazier Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
175,249
+23.0%
|
$12,617,928
$72.62 P/Share
|
|
Feb 26
2021
|
Michael Fleming SVP Chief Ethics & Com Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,437
+25.05%
|
$247,464
$72.62 P/Share
|
|
Feb 26
2021
|
Michael Nally EVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,127
+26.64%
|
$513,144
$72.62 P/Share
|
|
Feb 26
2021
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Grant, award, or other acquisition
|
Direct |
9,432
+9.25%
|
$679,104
$72.62 P/Share
|
|
Feb 26
2021
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
25,772
+21.67%
|
$1,855,584
$72.62 P/Share
|
|
Feb 26
2021
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,585
+24.32%
|
$906,120
$72.62 P/Share
|
|
Feb 26
2021
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
25,510
+18.28%
|
$1,836,720
$72.62 P/Share
|
|
Feb 26
2021
|
Robert M Davis Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
46,641
+17.64%
|
$3,358,152
$72.62 P/Share
|
|
Feb 26
2021
|
Jennifer Zachary EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,199
+43.88%
|
$1,742,328
$72.62 P/Share
|
|
Feb 26
2021
|
Steven Mizell EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,830
+43.48%
|
$1,283,760
$72.62 P/Share
|
|
Feb 26
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct |
6,052
+15.17%
|
$435,744
$72.62 P/Share
|
|
Feb 26
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,090
+31.32%
|
$150,480
$72.62 P/Share
|
|
Feb 26
2021
|
Dean Y Li Executive VP & President, MRL |
BUY
Grant, award, or other acquisition
|
Direct |
3,485
+24.65%
|
$250,920
$72.62 P/Share
|
|
Feb 10
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-12.76%
|
$35,025
$75.04 P/Share
|
|
Feb 10
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,167
+24.18%
|
$87,525
$75.04 P/Share
|